Esperion Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.About ESPR
Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets.
CEOSheldon L. Koenig
CEOSheldon L. Koenig
Employees304
Employees304
HeadquartersAnn Arbor, Michigan
HeadquartersAnn Arbor, Michigan
Founded1998
Founded1998
Employees304
Employees304
ESPR Key Statistics
Market cap228.92M
Market cap228.92M
Price-Earnings ratio-1.45
Price-Earnings ratio-1.45
Dividend yield—
Dividend yield—
Average volume2.85M
Average volume2.85M
High today$1.26
High today$1.26
Low today$1.14
Low today$1.14
Open price$1.18
Open price$1.18
Volume1.87M
Volume1.87M
52 Week high$3.94
52 Week high$3.94
52 Week low$0.6925
52 Week low$0.6925
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
14.3%
Sell
14.3%
People also own
Based on the portfolios of people who own ESPR. This list is generated using Robinhood data, and it’s not a recommendation.